Stockreport

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Addex Therapeutics Ltd - American Depositary Shares  (ADXN) 
PDF Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, April 21, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical com [Read more]